Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician

被引：10
作者：
Lohrmann, Graham M. [1 ]
Atwal, Danish [1 ]
Augoustides, John G. [2 ]
Askar, Wajih [3 ]
Patel, Prakash A. [2 ]
Ghadimi, Kamrouz [4 ,5 ]
Makar, Gerges [1 ]
Gutsche, Jacob T. [2 ]
Shamoun, Fadi E. [1 ]
Ramakrishna, Harish [3 ]
机构：
[1] Mayo Clin, Div Cardiovasc Dis, Scottsdale, AZ USA
[2] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA
[3] Mayo Clin, Dept Anesthesiol, Scottsdale, AZ USA
[4] Duke Univ, Med Ctr, Div Cardiothorac Anesthesiol, Durham, NC USA
[5] Duke Univ, Med Ctr, Div Crit Care, Durham, NC USA
来源：
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2016年 / 30卷 / 03期
关键词：
novel oral anticoagulants; dabigatran; rivaroxaban; edoxaban; apixaban; direct thrombin inhibitor; factor Xa; atrial fibrillation; activated charcoal; prothrombin complex concentrates; vitamin K antagonists; warfarin; recombinant factor VIM; idarucizumab; andexanet; aripazine; PROTHROMBIN COMPLEX CONCENTRATE; ACTIVATED FACTOR-VII; RECOMBINANT-FACTOR-VIIA; ATRIAL-FIBRILLATION; DABIGATRAN ETEXILATE; CARDIAC-SURGERY; CLINICAL-TRIAL; IDARUCIZUMAB; WARFARIN; RIVAROXABAN;
D O I：
10.1053/j.jvca.2016.01.005
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：823 / 830
页数：8
相关论文
共 50 条
  • [1] Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
    Enriquez, Andres
    Lip, Gregory Y. H.
    Baranchuk, Adrian
    EUROPACE, 2016, 18 (07): : 955 - 964
  • [2] Reversal of Direct Oral Anticoagulants: Current Status and Future Directions
    Weitz, Jeffrey I.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (01) : 40 - 50
  • [3] DIRECT ORAL ANTICOAGULANTS: NEW PERSPECTIVES ON REVERSAL AGENTS
    Imberti, D.
    Fontana, M.
    Benedetti, R.
    BLOOD TRANSFUSION, 2016, 14 : S691 - S694
  • [4] Perioperative management of patients on new oral anticoagulants
    Lai, A.
    Davidson, N.
    Galloway, S. W.
    Thachil, J.
    BRITISH JOURNAL OF SURGERY, 2014, 101 (07) : 742 - 749
  • [5] Direct oral anticoagulants: a review on the current role and scope of reversal agents
    Chaudhary, Rahul
    Sharma, Tushar
    Garg, Jalaj
    Sukhi, Ajaypaul
    Bliden, Kevin
    Tantry, Udaya
    Turagam, Mohit
    Lakkireddy, Dhanunjaya
    Gurbel, Paul
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (02) : 271 - 286
  • [6] Reversal agents for current and forthcoming direct oral anticoagulants
    van Es, Nick
    De Caterina, Raffaele
    Weitz, Jeffrey, I
    EUROPEAN HEART JOURNAL, 2023, 44 (20) : 1795 - 1806
  • [7] Bleeding and antidotes in new oral anticoagulants
    Majeed, Ammar
    Schulman, Sam
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 191 - 202
  • [8] Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke
    Frol, Senta
    Oblak, Janja Pretnar
    Sabovic, Miso
    van Zwam, Wim H.
    Ntaios, George
    Lovblad, Karl Olof
    Gruber, Andreas
    Kermer, Pawel
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [9] Reversal strategies in patients treated with direct oral anticoagulants
    Gressenberger, Paul
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2019, 48 (05) : 389 - 392
  • [10] New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
    Serrano-Sanchez, Victor
    Ripolles-de Ramon, Jorge
    Collado-Yurrita, Luis
    Vaello-Checa, Iris
    Colmenero-Ruiz, Constan-Tino
    Helm, Alexandra
    Ciudad-Cabanas, Maria-Jose
    Serrano-Cuenca, Victoriano
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2017, 22 (05): : E601 - E608
12345